SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-20-016730
Filing Date
2020-11-23
Accepted
2020-11-23 17:24:43
Documents
15
Period of Report
2020-11-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cort-20201123.htm   iXBRL 8-K 35622
2 EX-99.1 exhibit991pressrelease.htm EX-99.1 7663
  Complete submission text file 0001628280-20-016730.txt   193328

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cort-20201123.xsd EX-101.SCH 2458
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cort-20201123_cal.xml EX-101.CAL 744
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cort-20201123_def.xml EX-101.DEF 1689
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cort-20201123_lab.xml EX-101.LAB 25483
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cort-20201123_pre.xml EX-101.PRE 13281
8 EXTRACTED XBRL INSTANCE DOCUMENT cort-20201123_htm.xml XML 11016
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50679 | Film No.: 201339057
SIC: 2834 Pharmaceutical Preparations